Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 29

1.

Schizophrenia and co-occurring substance use disorder.

Green AI, Drake RE, Brunette MF, Noordsy DL.

Am J Psychiatry. 2007 Mar;164(3):402-8. No abstract available.

PMID:
17329463
2.

Substance abuse and schizophrenia: pharmacotherapeutic intervention.

Green AI, Noordsy DL, Brunette MF, O'Keefe C.

J Subst Abuse Treat. 2008 Jan;34(1):61-71. Epub 2007 Jun 15. Review.

3.

Treatment of schizophrenia and comorbid substance abuse: pharmacologic approaches.

Green AI.

J Clin Psychiatry. 2006;67 Suppl 7:31-5; quiz 36-7. Review.

4.

Schizophrenia and comorbid substance use disorder: effects of antipsychotics.

Green AI.

J Clin Psychiatry. 2005;66 Suppl 6:21-6. Review.

5.

[Pharmacotherapy of schizophrenia and comorbid substance use disorder. A systematic review].

Wobrock T, D'Amelio R, Falkai P.

Nervenarzt. 2008 Jan;79(1):17-8, 20-2, 24-6 passim. Review. German.

PMID:
17619840
6.

Management of schizophrenia with substance use disorders.

Lybrand J, Caroff S.

Psychiatr Clin North Am. 2009 Dec;32(4):821-33. doi: 10.1016/j.psc.2009.09.002. Review.

PMID:
19944886
7.

Substance abuse in schizophrenia: a review.

Buckley PF.

J Clin Psychiatry. 1998;59 Suppl 3:26-30. Review.

8.

Pharmacotherapy of schizophrenia with comorbid substance use disorder--reviewing the evidence and clinical recommendations.

Wobrock T, Soyka M.

Prog Neuropsychopharmacol Biol Psychiatry. 2008 Aug 1;32(6):1375-85. doi: 10.1016/j.pnpbp.2008.02.008. Epub 2008 Feb 26. Review.

PMID:
18394768
9.

Pharmacological treatment of schizophrenia with comorbid substance use disorder.

Azorin JM, Simon N, Adida M, Belzeaux R.

Expert Opin Pharmacother. 2016;17(2):231-53. doi: 10.1517/14656566.2016.1114101. Epub 2015 Dec 4. Review. Erratum in: Expert Opin Pharmacother. 2016;17(2):v.

PMID:
26635059
10.

Pharmacotherapy of patients with schizophrenia and substance abuse.

Wobrock T, Soyka M.

Expert Opin Pharmacother. 2009 Feb;10(3):353-67. doi: 10.1517/14656560802694655 . Review.

PMID:
19191675
11.

Drug abuse and addiction treatment research. The next generation.

Leshner AI.

Arch Gen Psychiatry. 1997 Aug;54(8):691-4. Review. No abstract available.

PMID:
9283502
12.

[Pharmacological therapies for alcohol use disorder in Japan].

Yumoto Y, Higuchi S.

Nihon Rinsho. 2015 Sep;73(9):1536-9. Review. Japanese.

PMID:
26394517
13.

Pharmacogenetics of alcohol use disorders and comorbid psychiatric disorders.

Helton SG, Lohoff FW.

Psychiatry Res. 2015 Dec 15;230(2):121-9. doi: 10.1016/j.psychres.2015.09.019. Epub 2015 Sep 14. Review.

PMID:
26455758
14.

Antipsychotic drug treatment of schizophrenic patients with substance abuse disorders.

San L, Arranz B, Martinez-Raga J.

Eur Addict Res. 2007;13(4):230-43. Review.

PMID:
17851245
15.

Recent developments in the pharmacotherapy of alcohol dependence.

Schuckit MA.

J Consult Clin Psychol. 1996 Aug;64(4):669-76. Review.

PMID:
8803356
16.

Treatment of schizophrenia and comorbid substance use disorder.

Green AI, Salomon MS, Brenner MJ, Rawlins K.

Curr Drug Targets CNS Neurol Disord. 2002 Apr;1(2):129-39. Review.

PMID:
12769622
17.

Management of substance use disorder in schizophrenia patients: current guidelines.

Drake RE.

CNS Spectr. 2007 Oct;12(10 Suppl 17):27-32. Review.

PMID:
17934387
18.

Enhancing validity in co-occurring disorders treatment research.

McHugo GJ, Drake RE, Brunette MF, Xie H, Essock SM, Green AI.

Schizophr Bull. 2006 Oct;32(4):655-65. Epub 2006 Jul 18. Review.

19.

Management of comorbid bipolar disorder and substance abuse.

Vornik LA, Brown ES.

J Clin Psychiatry. 2006;67 Suppl 7:24-30. Review.

20.

Treatment of dual diagnosis disorders.

Murthy P, Chand P.

Curr Opin Psychiatry. 2012 May;25(3):194-200. doi: 10.1097/YCO.0b013e328351a3e0. Review.

PMID:
22395768

Supplemental Content

Support Center